Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Multiple Myeloma industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Novartis AG
CELGENE CORPORATION(Bristol Myers Squibb company)
Genentech, Inc(FHoffmann-La Roche Ltd)
Karyopharm
Takeda Pharmaceutical Company Limited
Janssen Pharmaceuticals, Inc
Amgen Inc
Teva Pharmaceutical lndustries Ltd
Bristol Myers Squibb Company
ONO PHARMACEUTICAL CO,LTD
By Type:
Proteasome Inhibitor
Others
Anti-CD38 Monoclonal Antibody
Alkylating Agents
lmmunomodulators
By Application:
Retail Pharmacies & Drug Stores
Hospital Pharmacies
Online Pharmacies
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Multiple Myeloma Market Overview 2018-2029
-
1.1 China Multiple Myeloma Industry Development Overview
-
1.2 China Multiple Myeloma Industry Development History
-
1.3 China Multiple Myeloma Industry Market Size (2018-2029)
-
1.4 China Multiple Myeloma Market Analysis by Type from Production Side
-
1.4.1 China Multiple Myeloma Production Volume, Production Value and Growth Rate of Proteasome Inhibitor (2018-2029)
-
1.4.2 China Multiple Myeloma Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
1.4.3 China Multiple Myeloma Production Volume, Production Value and Growth Rate of Anti-CD38 Monoclonal Antibody (2018-2029)
-
1.4.4 China Multiple Myeloma Production Volume, Production Value and Growth Rate of Alkylating Agents (2018-2029)
-
1.4.5 China Multiple Myeloma Production Volume, Production Value and Growth Rate of lmmunomodulators (2018-2029)
-
1.5 China Multiple Myeloma Market Analysis by Application from Consumption End
-
1.5.1 China Multiple Myeloma Sales Volume, Sales Value and Growth Rate of Retail Pharmacies & Drug Stores (2018-2029)
-
1.5.2 China Multiple Myeloma Sales Volume, Sales Value and Growth Rate of Hospital Pharmacies (2018-2029)
-
1.5.3 China Multiple Myeloma Sales Volume, Sales Value and Growth Rate of Online Pharmacies (2018-2029)
-
1.6 China Multiple Myeloma Market Analysis by Region
-
1.6.1 North China Multiple Myeloma Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Multiple Myeloma Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Multiple Myeloma Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Multiple Myeloma Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Multiple Myeloma Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Multiple Myeloma Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Multiple Myeloma Market Size and Growth Rate from 2018-2029
Chapter 2 China Multiple Myeloma Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Multiple Myeloma Market Status and Competition at home and abroad in 2023
-
2.2.2 China Multiple Myeloma Market Status and Competition Analysis in 2023
-
2.2.3 China Multiple Myeloma Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Multiple Myeloma Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Multiple Myeloma Industry Development
Chapter 3 Multiple MyelomaIndustry Chain Analysis
-
3.1 Multiple Myeloma Industry Chain
-
3.2 Multiple Myeloma Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Multiple Myeloma Market
-
3.3 Multiple Myeloma Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Multiple Myeloma Market
Chapter 4 China Multiple Myeloma Market, by Type
-
4.1 China Multiple Myeloma Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Multiple Myeloma Total Production Volume and Growth Rate from Production Side
-
4.5 China Multiple Myeloma Production Volume and Growth Rate, by Type
-
4.5.1 China Multiple Myeloma Production Volume and Growth Rate of Proteasome Inhibitor
-
4.5.2 China Multiple Myeloma Production Volume and Growth Rate of Others
-
4.5.3 China Multiple Myeloma Production Volume and Growth Rate of Anti-CD38 Monoclonal Antibody
-
4.5.4 China Multiple Myeloma Production Volume and Growth Rate of Alkylating Agents
-
4.5.5 China Multiple Myeloma Production Volume and Growth Rate of lmmunomodulators
Chapter 5 China Multiple Myeloma Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Multiple Myeloma Total Market Size and Growth Rate from Consumption End
-
5.5 China Multiple Myeloma Market Size and Growth Rate, by Application
-
5.5.1 China Multiple Myeloma Market Size and Growth Rate of Retail Pharmacies & Drug Stores
-
5.5.2 China Multiple Myeloma Market Size and Growth Rate of Hospital Pharmacies
-
5.5.3 China Multiple Myeloma Market Size and Growth Rate of Online Pharmacies
Chapter 6 China Multiple Myeloma Market, by Region
-
6.1 China Multiple Myeloma Production Volume and Production Value, by Region
-
6.2 China Multiple Myeloma Sales Volume and Sales Value, by Region
Chapter 7 North China Multiple Myeloma Market Analysis
-
7.1 North China Multiple Myeloma Market, by Type
-
7.2 North China Multiple Myeloma Market, by Application
Chapter 8 Central China Multiple Myeloma Market Analysis
-
8.1 Central China Multiple Myeloma Market, by Type
-
8.2 Central China Multiple Myeloma Market, by Application
Chapter 9 South China Multiple Myeloma Market Analysis
-
9.1 South China Multiple Myeloma Market, by Type
-
9.2 South China Multiple Myeloma Market, by Application
Chapter 10 East China Multiple Myeloma Market Analysis
-
10.1 East China Multiple Myeloma Market, by Type
-
10.2 East China Multiple Myeloma Market, by Application
Chapter 11 Northeast China Multiple Myeloma Market Analysis
-
11.1 Northeast China Multiple Myeloma Market, by Type
-
11.2 Northeast China Multiple Myeloma Market, by Application
Chapter 12 Southwest China Multiple Myeloma Market Analysis
-
12.1 Southwest China Multiple Myeloma Market, by Type
-
12.2 Southwest China Multiple Myeloma Market, by Application
Chapter 13 Northwest China Multiple Myeloma Market Analysis
-
13.1 Northwest China Multiple Myeloma Market, by Type
-
13.2 Northwest China Multiple Myeloma Market, by Application
Chapter 14 Company Profiles
-
14.1 Novartis AG
-
14.1.1 Novartis AG Company Profile
-
14.1.2 Novartis AG Multiple Myeloma Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 CELGENE CORPORATION(Bristol Myers Squibb company)
-
14.2.1 CELGENE CORPORATION(Bristol Myers Squibb company) Company Profile
-
14.2.2 CELGENE CORPORATION(Bristol Myers Squibb company) Multiple Myeloma Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Genentech, Inc(FHoffmann-La Roche Ltd)
-
14.3.1 Genentech, Inc(FHoffmann-La Roche Ltd) Company Profile
-
14.3.2 Genentech, Inc(FHoffmann-La Roche Ltd) Multiple Myeloma Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Karyopharm
-
14.4.1 Karyopharm Company Profile
-
14.4.2 Karyopharm Multiple Myeloma Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Takeda Pharmaceutical Company Limited
-
14.5.1 Takeda Pharmaceutical Company Limited Company Profile
-
14.5.2 Takeda Pharmaceutical Company Limited Multiple Myeloma Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Janssen Pharmaceuticals, Inc
-
14.6.1 Janssen Pharmaceuticals, Inc Company Profile
-
14.6.2 Janssen Pharmaceuticals, Inc Multiple Myeloma Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Amgen Inc
-
14.7.1 Amgen Inc Company Profile
-
14.7.2 Amgen Inc Multiple Myeloma Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Teva Pharmaceutical lndustries Ltd
-
14.8.1 Teva Pharmaceutical lndustries Ltd Company Profile
-
14.8.2 Teva Pharmaceutical lndustries Ltd Multiple Myeloma Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Bristol Myers Squibb Company
-
14.9.1 Bristol Myers Squibb Company Company Profile
-
14.9.2 Bristol Myers Squibb Company Multiple Myeloma Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 ONO PHARMACEUTICAL CO,LTD
-
14.10.1 ONO PHARMACEUTICAL CO,LTD Company Profile
-
14.10.2 ONO PHARMACEUTICAL CO,LTD Multiple Myeloma Market Performance
-
14.10.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Multiple Myeloma Industry Research Conclusions
-
15.2 Multiple Myeloma Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Multiple Myeloma Industry Market Size (2018-2029)
-
Figure China Multiple Myeloma Production Volume, Production Value and Growth Rate of Proteasome Inhibitor (2018-2029)
-
Figure China Multiple Myeloma Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
Figure China Multiple Myeloma Production Volume, Production Value and Growth Rate of Anti-CD38 Monoclonal Antibody (2018-2029)
-
Figure China Multiple Myeloma Production Volume, Production Value and Growth Rate of Alkylating Agents (2018-2029)
-
Figure China Multiple Myeloma Production Volume, Production Value and Growth Rate of lmmunomodulators (2018-2029)
-
Figure China Multiple Myeloma Sales Volume, Sales Value and Growth Rate of Retail Pharmacies & Drug Stores (2018-2029)
-
Figure China Multiple Myeloma Sales Volume, Sales Value and Growth Rate of Hospital Pharmacies (2018-2029)
-
Figure China Multiple Myeloma Sales Volume, Sales Value and Growth Rate of Online Pharmacies (2018-2029)
-
Figure North China Multiple Myeloma Market Size and Growth Rate from 2018-2029
-
Figure Central China Multiple Myeloma Market Size and Growth Rate from 2018-2029
-
Figure South China Multiple Myeloma Market Size and Growth Rate from 2018-2029
-
Figure East China Multiple Myeloma Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Multiple Myeloma Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Multiple Myeloma Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Multiple Myeloma Market Size and Growth Rate from 2018-2029
-
Figure Multiple Myeloma Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Multiple Myeloma Market Share by Type in 2018
-
Figure China Multiple Myeloma Market Share by Type in 2023
-
Figure China Multiple Myeloma Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Multiple Myeloma Production Volume and Growth Rate of Proteasome Inhibitor (2018-2023)
-
Figure China Multiple Myeloma Production Volume and Growth Rate of Others (2018-2023)
-
Figure China Multiple Myeloma Production Volume and Growth Rate of Anti-CD38 Monoclonal Antibody (2018-2023)
-
Figure China Multiple Myeloma Production Volume and Growth Rate of Alkylating Agents (2018-2023)
-
Figure China Multiple Myeloma Production Volume and Growth Rate of lmmunomodulators (2018-2023)
-
Figure China Multiple Myeloma Market Share by Application in 2018
-
Figure China Multiple Myeloma Market Share by Application in 2023
-
Figure China Multiple Myeloma Total Market Size and Growth Rate from Consumption End
-
Figure China Multiple Myeloma Market Size and Growth Rate of Retail Pharmacies & Drug Stores (2018-2023)
-
Figure China Multiple Myeloma Market Size and Growth Rate of Hospital Pharmacies (2018-2023)
-
Figure China Multiple Myeloma Market Size and Growth Rate of Online Pharmacies (2018-2023)
-
Table China Multiple Myeloma Production Volume by Region (2018-2023)
-
Table China Multiple Myeloma Production Volume Share by Region (2018-2023)
-
Figure China Multiple Myeloma Production Volume Share by Region (2018-2023)
-
Table China Multiple Myeloma Production Value by Region (2018-2023)
-
Table China Multiple Myeloma Production Value Share by Region (2018-2023)
-
Figure China Multiple Myeloma Production Value Share by Region (2018-2023)
-
Table China Multiple Myeloma Sales Volume by Region (2018-2023)
-
Table China Multiple Myeloma Sales Volume Share by Region (2018-2023)
-
Figure China Multiple Myeloma Sales Volume Share by Region (2018-2023)
-
Table China Multiple Myeloma Sales Value by Region (2018-2023)
-
Table China Multiple Myeloma Sales Value Share by Region (2018-2023)
-
Figure China Multiple Myeloma Sales Value Share by Region (2018-2023)
-
Table North China Multiple Myeloma Production Volume by Type (2018-2023)
-
Table North China Multiple Myeloma Production Volume Share by Type (2018-2023)
-
Figure North China Multiple Myeloma Production Volume Share by Type (2018-2023)
-
Table North China Multiple Myeloma Sales Volume by Application (2018-2023)
-
Table North China Multiple Myeloma Sales Volume Share by Application (2018-2023)
-
Figure North China Multiple Myeloma Sales Volume Share by Application (2018-2023)
-
Table Central China Multiple Myeloma Production Volume by Type (2018-2023)
-
Table Central China Multiple Myeloma Production Volume Share by Type (2018-2023)
-
Figure Central China Multiple Myeloma Production Volume Share by Type (2018-2023)
-
Table Central China Multiple Myeloma Sales Volume by Application (2018-2023)
-
Table Central China Multiple Myeloma Sales Volume Share by Application (2018-2023)
-
Figure Central China Multiple Myeloma Sales Volume Share by Application (2018-2023)
-
Table South China Multiple Myeloma Production Volume by Type (2018-2023)
-
Table South China Multiple Myeloma Production Volume Share by Type (2018-2023)
-
Figure South China Multiple Myeloma Production Volume Share by Type (2018-2023)
-
Table South China Multiple Myeloma Sales Volume by Application (2018-2023)
-
Table South China Multiple Myeloma Sales Volume Share by Application (2018-2023)
-
Figure South China Multiple Myeloma Sales Volume Share by Application (2018-2023)
-
Table East China Multiple Myeloma Production Volume by Type (2018-2023)
-
Table East China Multiple Myeloma Production Volume Share by Type (2018-2023)
-
Figure East China Multiple Myeloma Production Volume Share by Type (2018-2023)
-
Table East China Multiple Myeloma Sales Volume by Application (2018-2023)
-
Table East China Multiple Myeloma Sales Volume Share by Application (2018-2023)
-
Figure East China Multiple Myeloma Sales Volume Share by Application (2018-2023)
-
Table Northeast China Multiple Myeloma Production Volume by Type (2018-2023)
-
Table Northeast China Multiple Myeloma Production Volume Share by Type (2018-2023)
-
Figure Northeast China Multiple Myeloma Production Volume Share by Type (2018-2023)
-
Table Northeast China Multiple Myeloma Sales Volume by Application (2018-2023)
-
Table Northeast China Multiple Myeloma Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Multiple Myeloma Sales Volume Share by Application (2018-2023)
-
Table Southwest China Multiple Myeloma Production Volume by Type (2018-2023)
-
Table Southwest China Multiple Myeloma Production Volume Share by Type (2018-2023)
-
Figure Southwest China Multiple Myeloma Production Volume Share by Type (2018-2023)
-
Table Southwest China Multiple Myeloma Sales Volume by Application (2018-2023)
-
Table Southwest China Multiple Myeloma Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Multiple Myeloma Sales Volume Share by Application (2018-2023)
-
Table Northwest China Multiple Myeloma Production Volume by Type (2018-2023)
-
Table Northwest China Multiple Myeloma Production Volume Share by Type (2018-2023)
-
Figure Northwest China Multiple Myeloma Production Volume Share by Type (2018-2023)
-
Table Northwest China Multiple Myeloma Sales Volume by Application (2018-2023)
-
Table Northwest China Multiple Myeloma Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Multiple Myeloma Sales Volume Share by Application (2018-2023)
-
Table Novartis AG Company Profile
-
Table Novartis AG Multiple Myeloma Revenue, Price and Gross (2018-2023)
-
Table CELGENE CORPORATION(Bristol Myers Squibb company) Company Profile
-
Table CELGENE CORPORATION(Bristol Myers Squibb company) Multiple Myeloma Revenue, Price and Gross (2018-2023)
-
Table Genentech, Inc(FHoffmann-La Roche Ltd) Company Profile
-
Table Genentech, Inc(FHoffmann-La Roche Ltd) Multiple Myeloma Revenue, Price and Gross (2018-2023)
-
Table Karyopharm Company Profile
-
Table Karyopharm Multiple Myeloma Revenue, Price and Gross (2018-2023)
-
Table Takeda Pharmaceutical Company Limited Company Profile
-
Table Takeda Pharmaceutical Company Limited Multiple Myeloma Revenue, Price and Gross (2018-2023)
-
Table Janssen Pharmaceuticals, Inc Company Profile
-
Table Janssen Pharmaceuticals, Inc Multiple Myeloma Revenue, Price and Gross (2018-2023)
-
Table Amgen Inc Company Profile
-
Table Amgen Inc Multiple Myeloma Revenue, Price and Gross (2018-2023)
-
Table Teva Pharmaceutical lndustries Ltd Company Profile
-
Table Teva Pharmaceutical lndustries Ltd Multiple Myeloma Revenue, Price and Gross (2018-2023)
-
Table Bristol Myers Squibb Company Company Profile
-
Table Bristol Myers Squibb Company Multiple Myeloma Revenue, Price and Gross (2018-2023)
-
Table ONO PHARMACEUTICAL CO,LTD Company Profile
-
Table ONO PHARMACEUTICAL CO,LTD Multiple Myeloma Revenue, Price and Gross (2018-2023)
-
